Följ
Ana Mallo-Abreu, ORCID: 0000-0002-5092-3538
Ana Mallo-Abreu, ORCID: 0000-0002-5092-3538
Juan de la Cierva Research Fellow at Universitat de Barcelona
Verifierad e-postadress på ub.edu - Startsida
Titel
Citeras av
Citeras av
År
3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and …
M Majellaro, W Jespers, A Crespo, MJ Núñez, S Novio, J Azuaje, ...
Journal of Medicinal Chemistry 64 (1), 458-480, 2020
232020
Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists
A Mallo-Abreu, R Prieto-Díaz, W Jespers, J Azuaje, M Majellaro, ...
Journal of Medicinal Chemistry 63 (14), 7721-7739, 2020
222020
Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition
A Mallo-Abreu, M Majellaro, W Jespers, J Azuaje, O Caamano, ...
Journal of Medicinal Chemistry 62 (20), 9315-9330, 2019
172019
Catalytic performance of a metal-free graphene oxide-Al2O3 composite assembled by 3D printing
J Azuaje, A Rama, A Mallo-Abreu, MG Boado, M Majellaro, CR Tubío, ...
Journal of the European Ceramic Society 41 (2), 1399-1406, 2021
142021
Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists
R Prieto-Díaz, M González-Gómez, H Fojo-Carballo, J Azuaje, ...
Journal of Medicinal Chemistry 66 (1), 890-912, 2022
92022
Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists
D Miranda-Pastoriza, R Bernárdez, J Azuaje, R Prieto-Díaz, M Majellaro, ...
ACS Medicinal Chemistry Letters 13 (2), 243-249, 2022
52022
Potent and Subtype-Selective Dopamine D2 Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach
A Mallo-Abreu, I Reyes-Resina, J Azuaje, R Franco, A García-Rey, ...
Journal of Medicinal Chemistry 64 (12), 8710-8726, 2021
42021
Exploring Biginelli-based scaffolds as A2B adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal …
R Prieto-Díaz, H Fojo-Carballo, M Majellaro, T Tandarić, J Azuaje, J Brea, ...
Biomedicine & pharmacotherapy 173, 116345, 2024
2024
New ligands and pharmacological tools for the study of g protein-coupled receptors using multicomponent reactions
AM Abreu
New ligands and pharmacological tools for the study of g protein-coupled …, 2021
2021
3, 4-Dihydropyrimidin-2 (1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and Enantiospecific Recognition
M Majellaro, W Jespers, A Crespo, MJ Núñez, S Novio, J Azuaje, ...
Journal of Medicinal Chemistry 64 (1), 458-480, 2021
2021
New Ligands and Pharmacological Tools for the Study of G Protein-Coupled Receptors Using Multicomponent Reactions
A Mallo Abreu
A Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists
MA Ana, PD Ruben, J Willem, A Jhonny, M Maria, V Carmen, GM Xerardo, ...
Journal of medicinal chemistry, 0
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–12